{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012", "Q3", 304931, "EMERGENT BIOSOLUTIONS INC.", 181344, "EMERGENT BIOSOLUTIONS INC", 2011, "third_quarter", "2011-10-19T11:09:38.977000-04:00", 630000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012/\", \"filing_uuid\": \"5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2011, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"630000.00\", \"expenses_method\": \"c\", \"expenses_method_display\": \"Method C - Reporting amounts under section 162(e) of the Internal Revenue Code\", \"posted_by_name\": \"Allen M Shofe, Senior Vice President Corporate Affairs\", \"dt_posted\": \"2011-10-19T11:09:38.977000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1455 Pennsylvania Avenue, NW\", \"registrant_address_2\": \"SUITE 1225\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20004\", \"registrant\": {\"id\": 304931, \"url\": \"https://lda.senate.gov/api/v1/registrants/304931/\", \"house_registrant_id\": 38213, \"name\": \"EMERGENT BIOSOLUTIONS INC.\", \"description\": null, \"address_1\": \"1455 Pennsylvania Avenue, NW\", \"address_2\": \"SUITE 1225\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"LIZ HANPETER\", \"contact_telephone\": \"+1 202-270-7978\", \"dt_updated\": \"2026-01-20T20:36:48.745096-05:00\"}, \"client\": {\"id\": 181344, \"url\": \"https://lda.senate.gov/api/v1/clients/181344/\", \"client_id\": 12, \"name\": \"EMERGENT BIOSOLUTIONS INC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-07-26\"}, \"lobbying_activities\": [{\"general_issue_code\": \"DIS\", \"general_issue_code_display\": \"Disaster Planning/Emergencies\", \"description\": \"Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) &  Project BioShield relating to stockpiling of biodefense vaccines.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 30597, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ALLEN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SHOFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1102, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ASHLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRATICH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 47773, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHRIS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FRECH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53714, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JILL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAMAKER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) &  Project BioShield relating to stockpiling of biodefense vaccines.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 30597, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ALLEN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SHOFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1102, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ASHLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRATICH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 47773, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHRIS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FRECH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53714, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JILL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAMAKER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HOM\", \"general_issue_code_display\": \"Homeland Security\", \"description\": \"Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) &  Project BioShield relating to stockpiling of biodefense vaccines.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 30597, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ALLEN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SHOFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1102, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ASHLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRATICH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 47773, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHRIS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FRECH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53714, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JILL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAMAKER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012"], "units": {}, "query_ms": 10.066218907013535, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}